Patent Application Titled "Cd73 Antigen-Binding Protein And Application Thereof" Published Online (USPTO 20240026024).
In: Cancer Weekly, 2024-02-13, S. 1601-1601
serialPeriodical
Zugriff:
A patent application titled "Cd73 Antigen-Binding Protein And Application Thereof" has been published online. The inventors have developed an isolated antigen-binding protein that specifically binds to CD73, a protein that is overexpressed in tumor cells and associated with poor prognosis. This protein has the ability to inhibit CD73's enzymatic activity and induce endocytosis of CD73 on the cell surface. The patent application also includes information about other molecules and compositions that contain the antigen-binding protein. This invention has potential applications in the prevention, treatment, and detection of CD73-mediated diseases and disorders, including breast cancer. [Extracted from the article]
Copyright of Cancer Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Patent Application Titled "Cd73 Antigen-Binding Protein And Application Thereof" Published Online (USPTO 20240026024).
|
---|---|
Zeitschrift: | Cancer Weekly, 2024-02-13, S. 1601-1601 |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
ISSN: | 1071-7218 (print) |
Schlagwort: |
|
Sonstiges: |
|